Why The Optusman System Works
Sub-Dermal Delivery
0.5mm gold micro-needles bypass the skin barrier entirely, delivering actives up to 30 X deeper than any topical serum - directly to the follicle layer.
Clinically Evidenced
82% of men saw significant regrowth in a peer-reviewed randomised controlled trial. Every ingredient is backed by published research at a clinically active concentration.
33 Active Ingredients
GHK-Cu, Rosemary Extract, Acetyl Tetrapeptide-3, and 30 further -targeting every driver of hair loss simultaneously.
120-Day Guarantee
The science backs it. So do we. Use Optusman for a full 120 days - if you don't see visible improvement during this time, we'll refund in full.
Built On Published Clinical Research
The Optusman system wasn't assembled from trending ingredients. Every active was selected because it has peer-reviewed evidence behind it, at a concentration shown to be clinically active. The delivery mechanism - 0.5mm gold micro-infusion - is the same approach validated in a randomised controlled trial of 100 men that produced 4X greater hair count improvement than topical treatment alone.
Evidence-Based Formula
All 33 actives selected from peer-reviewed literature. Concentrations matched to clinically effective ranges - not minimum viable doses included for label appeal.
Fully Transparent
Full INCI list, concentrations, and clinical citations all published on this page. No proprietary blend hiding. No undisclosed actives. We show our work because we are confident in it.
The Optusman Formula
0.3% GHK-Cu - Copper Peptide
5% Acetyl Tetrapeptide-3
2% Rosemary Leaf Extract
1% Caffeine
1% Biotin (Vitamin B7)
2% Ascorbic Acid (Vitamin C)
2% Tea Tree Oil
1.5% Eucalyptus Oil
Optusman vs the alternatives.
We're pro-science. Many customers use Optusman alongside physician-guided therapies. This table is honest — it shows where each option wins and where it doesn't.
|
Optusman
GHK-Cu Micro-Infusion
Twice weekly · UK |
Minoxidil
Topical or oral
|
Finasteride
Prescription oral
|
Hair Transplant
Surgical procedure
|
Derma Roller
Device only, no formula
|
|
|---|---|---|---|---|---|
| Cost & Commitment | |||||
| Entry cost | £44.95 | £25–40 | £20–60/mo (Rx) | £5,000–15,000 | £15–80 |
| Application frequency | Twice weekly BEST | Twice daily, every day | Once daily, indefinitely | Single procedure | 1–2x per week (no actives) |
| Time to visible results | 6–12 weeks (clinical data) | 3–6 months | 3–12 months | 9–18 months post-op | Uncertain without actives |
| Formula Transparency | |||||
| Concentrations disclosed |
All 33 actives
ONLY BRAND
|
% on label
|
Rx standardised
|
N/A |
No serum
|
| PubMed citations per ingredient |
Yes — all key actives
|
Yes — extensive literature
|
Yes — extensive literature
|
Yes — surgical literature
|
Device only
|
| Safety Profile | |||||
| Prescription required |
No
|
No (topical)
|
Yes — GP required
|
Yes — surgical consult
|
No
|
| Hormonal interference |
None
|
None (topical)
|
Systemic DHT reduction
|
None
|
None
|
| Sexual side effect risk |
None documented
|
Rare with topical form
|
Documented in literature
Irwig 2012
|
None
|
None
|
| Dependency / reversal on stopping | No dependency created |
Rapid reversal in months
|
Reversal within 6–12 months
|
Permanent (redistributed hairs)
|
No dependency
|
| Efficacy & Delivery | |||||
| Delivery past skin barrier |
Direct — micro- channels
STRONGEST
|
Limited — follicular shunt only
|
Oral — systemic absorption
|
Direct — surgical
|
Channels only, no actives
|
| GHK-Cu copper peptides |
0.3% — disclosed
|
|
|
|
|
|
Rosemary Extract
≡ Minoxidil 2% in Panahi 2015 RCT |
2% — disclosed
|
|
|
|
|
| Multi-pathway scalp actives |
3 pathways — Caffeine, Zinc PCA, Rosemary
|
Not applicable
|
Single pathway — 5AR inhibition
|
Not applicable
|
Not applicable
|
| Guarantee & Support | |||||
| Money-back guarantee |
90 days — no return required
STRONGEST
|
Retailer-dependent
|
Prescription — no refund
|
Non-refundable surgery
|
Retailer-dependent
|
| UK native brand |
UK-based
|
Various origins
|
Various origins
|
Clinic-dependent
|
Various origins
|
This comparison reflects published clinical literature and publicly available product information as of April 2026. Finasteride sexual side effect data: Irwig M.S. (2012) J Sex Med 9(11):2927–2932. Minoxidil reversal: Messenger A.G. & Rundegren J. (2004) Br J Dermatol 150(2):186–194. Rosemary vs Minoxidil: Panahi Y. et al. (2015) SKINmed 13(1):15–21. Hair transplant timeline: NHS guidance on hair transplant procedures. Microneedling RCT: Dhurat R. et al. (2013) Int J Trichology 5(1):6–11, PubMed 23960389. We acknowledge that all options shown have clinical evidence supporting their use. Optusman is not a replacement for medical advice. If considering Finasteride or hair transplant, consult a qualified clinician.
Ready To Start With The Evidence?
£44.95 · Complete first kit · Free UK delivery · No prescription · No hormones
Before & After Results
What Hair Specialists Say About Micro-Infusion
Advisor Testimonial
Advisor Testimonial
Advisor Testimonial
Primary References
Legal disclaimer: All clinical statistics cited on this page are drawn from independent, peer-reviewed academic studies and do not constitute claims specific to the Optusman product. Individual results vary. Consult a healthcare professional if you have concerns about hair loss. Optusman is a cosmetic micro-infusion system designed to support scalp health and the visible appearance of fuller, denser hair with consistent use. It is not a medical device and is not intended to diagnose, treat, cure or prevent any medical condition. Individual results vary. If you are experiencing significant or sudden hair loss, we recommend consulting a qualified clinician.